Regenerative Medicine Medical Device Start Up Receives Funding Boost
Born of expertise developed at the McGowan Institute for Regenerative Medicine, medical device startup company Neograft Technologies was formed in 2009 and is developing Angioshield™, an intraperative system that creates a micro-fibrous, polymer sleeve intimately surrounding the outside surface of a harvested vein to mechanically reinforce and protect it from overdilation. This work emerges from the University of Pittsburgh by company founders Drs. Mohammed El-Kurdi and Lorenzo Soletti and their academic advisors, McGowan Institute for Regenerative Medicine faculty member David Vorp, PhD, and McGowan Institute for Regenerative Medicine interim director William Wagner, PhD.
Recent Regenerative Medicine News
- Regenerative Medicine Medical Device Start Up Receives Funding Boost
- Long Distance Warrior: The Story of Bill McGowan
- Clinical Use of New Brain-Scanning Technology
- Regenerative Medicine: Regrowing Blood Vessels with a Potent Molecule
- Dr. Steven Little Awarded the 2012 Young Investigator Award from the Society For Biomaterials
- Team Describes How Tooth Enamel Forms
- Regenerative Medicine’s Potential Fountain of Youth
- Dr. Alan Russell, Inaugural Editor-in-Chief of New Peer-Reviewed Journal
- Regenerative Medicine Technique Highlighted on The Dr. Oz Show
- Accolades to McGowan Institute for Regenerative Medicine Faculty Members
- See Regenerative Medicine In the News Archive and Search Feature